A fast-growing Mid-Level (public stock listed USA) company selected mIRT XPRESS
As protocols turn out to be more complex and clinical trials become more patient-centric, clinical trial supply management is going to be one of the decisive factors for the success of clinical trials strategy.
Most Companies need IRT systems that are flexible, quick to setup, site and supply manager-friendly, and highly dependable.
This led to one of a Mid-Level fast-growing public company to select for mIRT XPRESS which is the only NO-Build system in the market currently available. After considering several vendors, this sponsor selected DDi’s mIRT XPRESS because it enables Clinical Trial supply teams in full control with super-fast implementation, flexibility and more importantly the best COST point comparatively.